Corrigendum to “Hexyl-pentynoic acid serves as a novel radiosensitizer for breast cancer by inhibiting UCHL3-dependent Rad51 deubiquitination” [Radiat. Med. Protect. (2023) 204–213]
Zuchao Cai et al · Elsevier · 2026
Acceso al recurso
Entrá al contenido desde la opción principal o elegí otra fuente disponible.
Acceso abierto disponible
Cómo citar
Elegí el formato que necesitás y copiá la referencia al portapapeles.
APA 7
al, Z. C. E. (2026). Corrigendum to “Hexyl-pentynoic acid serves as a novel radiosensitizer for breast cancer by inhibiting UCHL3-dependent Rad51 deubiquitination” [Radiat. Med. Protect. (2023) 204–213]. https://doi.org/10.1016/j.radmp.2025.12.006
MLA
al, Zuchao Cai et. "Corrigendum to “Hexyl-pentynoic acid serves as a novel radiosensitizer for breast cancer by inhibiting UCHL3-dependent Rad51 deubiquitination” [Radiat. Med. Protect. (2023) 204–213]." 2026. https://doi.org/10.1016/j.radmp.2025.12.006.
Chicago
al, Zuchao Cai et. 2026. "Corrigendum to “Hexyl-pentynoic acid serves as a novel radiosensitizer for breast cancer by inhibiting UCHL3-dependent Rad51 deubiquitination” [Radiat. Med. Protect. (2023) 204–213].". https://doi.org/10.1016/j.radmp.2025.12.006.
Harvard
al, Z. C. E. 2026, Corrigendum to “Hexyl-pentynoic acid serves as a novel radiosensitizer for breast cancer by inhibiting UCHL3-dependent Rad51 deubiquitination” [Radiat. Med. Protect. (2023) 204–213], Elsevier, available at: https://doi.org/10.1016/j.radmp.2025.12.006 [Accessed 2 Jul. 2026].
Detalles del recurso
Información bibliográfica útil para confirmar que se trata del material correcto.
- Título
- Corrigendum to “Hexyl-pentynoic acid serves as a novel radiosensitizer for breast cancer by inhibiting UCHL3-dependent Rad51 deubiquitination” [Radiat. Med. Protect. (2023) 204–213]
- Autor / colaboradores
- Zuchao Cai et al
- Editorial
- Elsevier
- Año de publicación
- 2026
- ISSN
- 2666-5557
- ISSN
- 2666-5557
- Idioma
- eng